US-Israeli Aggression Against Iran Fuels Global Medicine Price Hike
The relentless war waged by the United States and Israel against the Islamic Republic of Iran has unleashed a cascade of economic repercussions, driving up the prices of essential goods worldwide. While initial concerns rightly focused on the global supply of oil, gas, and fertilizers, the crisis has now critically impacted the availability and cost of vital medicines and contraceptives.
Pharmacists globally are reporting alarming spikes in prices. In the United Kingdom, over-the-counter medicines have seen a 20 to 30 percent increase, with the common painkiller paracetamol quadrupling in price. Similarly, Indian chemists are grappling with price surges of up to 96 percent for common painkillers, underscoring the severe global reach of this conflict’s economic fallout.
Why are Medicine Prices Soaring?
The primary catalyst for this alarming trend is the disruption of critical supply chains. Following the intensification of the conflict, Iran’s strategic decision to block the Strait of Hormuz – a vital artery through which 20 percent of the world’s oil and liquefied natural gas (LNG) supplies transit – has had far-reaching consequences. This measure, a direct response to the ongoing aggression, has inadvertently crippled pharmaceutical supply chains, which are heavily reliant on oil and petrochemical feedstocks.
Frederic Schneider, a nonresident senior fellow at the Middle East Council on Global Affairs, highlighted the intricate link: “Pharmaceuticals are tied to both petrochemical feedstocks, a large part of which are sourced through the Persian Gulf.” He further elaborated on the vulnerability of logistics routes, particularly those between East Asia and Europe, which rely on transhipment stops in the Gulf, especially Dubai. “These routes are especially fragile because many pharmaceuticals need special handling, including an unbroken cold chain. Both have been disrupted through the war,” Schneider explained.
Professor Wouter Dewulf, an expert in pharma logistics from the University of Antwerp, warned that while pharmaceutical supply chains are not in immediate danger of collapse, medicines are highly exposed to air logistics. The US-Israel war on Iran has caused severe disruption for airlines, leading to widespread cancellations, airspace closures, and a looming jet fuel crisis.
“35 percent of pharmaceuticals move by air, and about 90 percent of critical or life-saving pharmaceuticals and vaccines do so too,” Dewulf stated, estimating that “22 percent of global air cargo flows are exposed to Middle East disruptions.”
The immediate global effect is primarily delays, rerouting, and higher costs, rather than a widespread physical shortage. However, modest price increases on pharmaceuticals are inevitable due to rising air cargo fares, particularly on east-west corridors. Generic medicines, with their thinner margins, are expected to experience a relatively higher price surge.
Which Pharma Products Are Most Affected?
- Condoms: Goh Miah Kiat, CEO of Karex, the world’s leading condom producer, announced a necessary 20 to 30 percent price increase. This is a direct consequence of the ongoing supply chain disruptions, which have left vast quantities of essential products stranded at sea.
- Paracetamol: This common painkiller has seen dramatic price hikes. Reports from the UK and India indicate significant increases, with some regions in India reporting a 96 percent rise. The surge is attributed to the escalating cost of raw materials, with further increases anticipated.
Global Impact and Vulnerabilities
The global impact of these price increases varies, heavily dependent on factors such as the availability of alternative suppliers and strategic stockpiling. While nations like the US and China possess more resilient supply chains, countries like India, a major pharmaceutical producer, face significant challenges due to their reliance on Gulf supplies.
Schneider highlighted the critical role of strategic stockpiling, noting that while some Global North countries like the EU and the UK have mechanisms in place, the situation is far more dire for the Global South, particularly sub-Saharan Africa. These regions, often lacking sufficient stockpiles and financial capacity, are disproportionately affected by the price increases and supply crunch. Countries already enduring humanitarian crises, such as Sudan, Yemen, and Palestine, face an even grimmer outlook.
Dewulf further emphasized that the real exposure is most acute in nations directly impacted by the conflict and regional instability, including Lebanon, Palestine, and Iran. He also identified fragile, aid-dependent countries as a second vulnerable group, and import-dependent Gulf markets, especially for cold-chain and cancer medicines, as a third risk group. Despite some gradual recovery in airlifts, the situation remains precarious, with risks and delays persisting.
#USIsraelWar #IranConflict #MedicinePrices #GlobalHealthCrisis #SupplyChainDisruption #StraitOfHormuz #Pharmaceuticals #EconomicImpact #GlobalSouth #HumanitarianCrisis